Congenital Adrenal Hyperplasia Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
Salt Wasting, Hydro-sodium Balance and Fludrocortisone Requirement in Congenital Adrenal Hyperplasia
Condition: Congenital Adrenal Hyperplasia (CAH) Intervention: Sponsor: Assistance Publique - Hôpitaux de Paris Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 8, 2018 Category: Research Source Type: clinical trials
Salt Wasting, Hydro-sodium Balance and Fludrocortisone Requirement in Congenital Adrenal Hyperplasia
Condition: Congenital Adrenal Hyperplasia (CAH) Intervention: Sponsor: Assistance Publique - Hôpitaux de Paris Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 8, 2018 Category: Research Source Type: clinical trials
Androgen Reduction in Congenital Adrenal Hyperplasia
Condition: Congenital Adrenal Hyperplasia Interventions: Drug: Abiraterone acetate; Drug: Placebo; Drug: Hydrocortisone; Drug: Fludrocortisone Sponsors: University of Texas Southwestern Medical Center; National Institutes of Health Clinical Center (CC); University of Michigan; Children's Hospital Los Angeles; Feinstein Institute for Medical Research Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 7, 2018 Category: Research Source Type: clinical trials